Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.

Angiogenesis is a fundamental process in tumor growth and metastasis, and its significance and that of vascular endothelial growth factor (VEGF) expression as prognostic indicators have been documented for various types of human tumors. However, the mechanisms responsible for angiogenesis in head and neck squamous cell carcinoma are not well defined. To examine the relationship between angiogenesis and the phenotypic progressions of head and neck tumorigenesis, we used immunohistochemistry to analyze VEGF expression and microvessel density in 70 paraffin-embedded specimens that contained adjacent normal epithelium, premalignant lesions, or both from 57 patients with head and neck squamous cell carcinoma. Ten samples of normal oral mucosa were obtained from people who did not smoke or drink alcohol and included in the analysis as normal controls. Microvessel density was evaluated by averaging 10 microscopic fields (x400) in a defined area of each specimen. The degree of VEGF expression was assessed on a cell-by-cell basis in 10 microscopic fields (x200) in a defined area on a scale ranging from 0 (no expression) to 3+ (highest level of expression). In addition, the weighted mean index of VEGF expression was calculated. The mean +/- SD weighted mean index of VEGF expression in normal control epithelium (1.10 +/- 0.38, n = 10) was higher than it was in adjacent normal epithelium (0.82 +/- 0.27, n = 13; P = 0.04). VEGF expression decreased as samples ranged from normal adjacent epithelium to hyperplasia (0.78 +/- 0.28, n = 21), mild dysplasia (0.70 +/- 0.29, n = 28), moderate dysplasia (0.67 +/- 0.29, n = 11), severe dysplasia (0.51 +/- 0.39, n = 6), and squamous cell carcinoma (0.20 +/- 0.27, n = 70; overall P = 0.0001). VEGF expression was two times lower in cases with nodal disease (0.17 +/- 0.26, n = 29) than it was in nonnodal disease (0.32 +/- 0.29, n = 16; P = 0.02). Microvessel density showed no significant difference from adjacent normal epithelium premalignant lesions to cancer. In tumor, no correlation was seen between VEGF expression or microvessel density and differentiation, primary tumor site, T stage, or smoking status. These findings indicate that VEGF expression is down-regulated during head and neck tumorigenesis. However, further studies are required to better understand the mechanism of VEGF down-regulation in head and neck tumorigenesis.

[1]  I. Zachary.  Vascular endothelial growth factor. , 1998, The international journal of biochemistry & cell biology.

[2]  M. Mildner,et al.  Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals , 1998, The Journal of pathology.

[3]  S. Furukawa,et al.  Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status. , 1998, Journal of clinical pathology.

[4]  K. Haruma,et al.  Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  P. Wright,et al.  Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium. , 1998, Experimental and molecular pathology.

[6]  C. Bucana,et al.  Regulation of distinct steps of angiogenesis by different angiogenic molecules. , 1998, International journal of oncology.

[7]  Anthony J. Guidi,et al.  Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[8]  C. Cohen,et al.  Tumor angiogenesis as a prognostic factor in laryngeal cancer. , 1997, American journal of surgery.

[9]  P. Heikkilä,et al.  Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[10]  D. Kreutzer,et al.  Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. , 1997, American journal of surgery.

[11]  H. Moch,et al.  Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations. , 1997, Gynecologic oncology.

[12]  E Yamamoto,et al.  Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. , 1997, Oral oncology.

[13]  G. Ogden,et al.  The association between tumour progression and vascularity in the oral mucosa , 1997, The Journal of pathology.

[14]  J. Gluckman,et al.  Tumor angiogenesis as a prognostic indicator in T2‐T4 oral cavity squamous cell carcinoma: A clinical‐pathologic correlation , 1997, Head & neck.

[15]  C. Ballaun,et al.  Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[16]  A. Ferrari,et al.  Vascular endothelial growth factor. Expression in human vulvar neoplastic and nonneoplastic tissues. , 1996, The Journal of reproductive medicine.

[17]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[18]  M. Oda,et al.  Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  J. Niloff,et al.  Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[20]  D. Gomez,et al.  Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. , 1996, Cancer research.

[21]  M. Rocchi,et al.  Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. , 1996, Circulation.

[22]  S. Fox,et al.  Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.

[23]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[24]  L. Ellis,et al.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. , 1995, Cancer research.

[25]  N. Hardin,et al.  Angiogenesis as a Prognostic Marker in Early Head and Neck Cancer , 1995, The Annals of otology, rhinology, and laryngology.

[26]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[27]  W. Hong,et al.  Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. , 1994, Cancer research.

[28]  M. Granick,et al.  The Relationship of Angiogenesis to Biological Activity in Human Squamous Cell Carcinomas of the Head and Neck , 1994, Annals of plastic surgery.

[29]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[30]  K. Smith-McCune,et al.  Demonstration and characterization of the angiogenic properties of cervical dysplasia. , 1994, Cancer research.

[31]  W. Hong,et al.  Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. , 1994, Cancer research.

[32]  N. Weidner,et al.  Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma , 1993, International journal of cancer.

[33]  E. Manseau,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. , 1993, Cancer research.

[34]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[35]  W. Hong,et al.  Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. , 1993, Journal of the National Cancer Institute.

[36]  H. Dvorak,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.

[37]  C. Angeletti,et al.  Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.

[38]  J. Monson,et al.  Is the relationship between angiogenesis and metastasis in breast cancer real? , 1992, Surgical oncology.

[39]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[40]  G. Breier,et al.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.

[41]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[42]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[43]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[44]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[45]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[46]  A. Srivastava,et al.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.

[47]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[48]  E. Farber.  The multistep nature of cancer development. , 1984, Cancer research.

[49]  R. Weinberg,et al.  A molecular basis of cancer. , 1983, Scientific American.

[50]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[51]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[52]  S. Leurgans,et al.  Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer. , 1998, Archives of otolaryngology--head & neck surgery.

[53]  K. Chew,et al.  Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.

[54]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[55]  C. Ballaun,et al.  Human keratinocytes express the three major splice forms of vascular endothelial growth factor. , 1995, The Journal of investigative dermatology.

[56]  N. Weidner,et al.  Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.